Trial intelligence / Profile preview

Intraperitoneal Chemotherapy for Advanced Gastric Cancer

NCT00992199Phase 2Unknown

Sponsor
Fudan University
Start
Aug 2009
Primary completion
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of cisplatin and fluorouracil in gastric cancer (GC) (2 arms), sponsored by Fudan University. Primary endpoint: Metastasis in Peritoneum and peritoneal cavity at 1 year. Status: unknown.

02

Drugs

cisplatinfluorouracil
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT00992199.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00992199.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call